Annals of Behavioral Medicine

, Volume 43, Issue 3, pp 352–361 | Cite as

Acute Exercise Improves Physical Sexual Arousal in Women Taking Antidepressants

Original Article

Abstract

Background

Antidepressants can impair sexual arousal. Exercise increases genital arousal in healthy women, likely due to increasing sympathetic nervous system (SNS) activity.

Purpose

Test if exercise increases genital arousal in women taking antidepressants, including selective serotonin reuptake inhibitors (SSRIs), which suppress SNS activity, and selective serotonin and norepinephrine reuptake inhibitors (SNRIs), which suppress the SNS less.

Method

Women reporting antidepressant-related sexual arousal problems (N = 47) participated in three counterbalanced sessions where they watched an erotic film while we recorded genital and SNS arousal. In two sessions, women exercised for 20 min, either 5 or 15 min prior to the films.

Results

During the no-exercise condition, women taking SSRIs showed significantly less genital response than women taking SNRIs. Exercise prior to sexual stimuli increased genital arousal in both groups. Women reporting greater sexual dysfunction had larger increases in genital arousal post-exercise. For women taking SSRIs, genital arousal was linked to SNS activity.

Conclusions

Exercise may improve antidepressant-related genital arousal problems.

Keywords

Antidepressant side effects Sexual arousal functioning Exercise Sympathetic nervous system activity 

References

  1. 1.
    Olfson M, Marcus S, Druss B, et al.: National trends in the outpatient treatment of depression. JAMA. 2002, 287:203–209.PubMedCrossRefGoogle Scholar
  2. 2.
    Ashton A, Rosen R: Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Marital Ther. 1998, 24:191–192.PubMedCrossRefGoogle Scholar
  3. 3.
    Thiels C, Linden M, Grieger F, Leonard J: Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psychopharmacol. 2005, 20:1–23.PubMedCrossRefGoogle Scholar
  4. 4.
    Paulose-Ram R, Safran M, Jonas B, Gu Q, Orwig D: Trends in psychotropic medication use among US adults. Pharmacoepidem Dr S. 2007, 16:560–570.CrossRefGoogle Scholar
  5. 5.
    Clayon A, Keller A, McGarvey EL: Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord. 2006, 91:27–32.CrossRefGoogle Scholar
  6. 6.
    Rosen R, Lane R, Menza M: Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol. 1999, 19:67–85.PubMedCrossRefGoogle Scholar
  7. 7.
    Werneke U, Northey S, Bhugra D: Antidepressants and sexual dysfunction. Acta Psychiatr Scand. 2006, 114:384–397.PubMedCrossRefGoogle Scholar
  8. 8.
    Taylor M, Rudkin L, Hawton K: Strategies for managing antidepressant-induced sexual dysfunction: Systematic review of randomised controlled trials. J Affect Disord. 2005, 88:241–254.PubMedCrossRefGoogle Scholar
  9. 9.
    Perlis R, Fava M, Nierenberg A, et al.: Strategies for treatment of SSRI-associated sexual dysfunction: A survey of an academic psychopharmacology practice. Harv Rev Psychiatry. 2002, 10:109–114.PubMedGoogle Scholar
  10. 10.
    Nurnberg H, Hensley P, Heiman J, et al.: Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial. JAMA. 2008, 300:395–404.PubMedCrossRefGoogle Scholar
  11. 11.
    Safarinejad MR: Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: A double-blind, placebo-controlled and randomized study. J Psychopharmacol (Oxf). 2011, 25:370–378.CrossRefGoogle Scholar
  12. 12.
    Masand PS, Ashton AK, Gupta S, Frank B: Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: A randomized, double-blind, placebo-controlled, parallel-group study. A J Psychiatry. 2001, 158:805–807.CrossRefGoogle Scholar
  13. 13.
    Souery D, Amsterdam J, De Montigny C, et al.: Treatment resistant depression: Methodological overview and operational criteria. Eur Neuropsychopharmacol. 1999, 9:83–91.PubMedCrossRefGoogle Scholar
  14. 14.
    Montejo A: Are sexual disorders core symptoms of depression? Medicographia. 2008, 30:24–29.Google Scholar
  15. 15.
    Serretti A, Chiesa A: Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. J Clin Psychopharmacol. 2009, 29:259–266.PubMedCrossRefGoogle Scholar
  16. 16.
    Millan M, Lejeune F, Gobert A: Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: Relevance to the actions of antidepressant agents. J Psychopharmacol (Oxf). 2000, 14:114–138.CrossRefGoogle Scholar
  17. 17.
    Gothert M, Fink K, Frolich D, et al.: Presynaptic 5-HT auto-and heteroreceptors in the human central and peripheral nervous system. Behav Brain Res. 1995, 73:89–92.CrossRefGoogle Scholar
  18. 18.
    Enguix M, Sanchez L, Villazun M, et al.: Differential regulation of rat peripheral 5-HT 2A and 5-HT 2B receptor systems: Influence of drug treatment. N-S Arch Pharmacol. 2003, 368:79–90.CrossRefGoogle Scholar
  19. 19.
    Hull E, Muschamp J, Sato S: Dopamine and serotonin: Influences on male sexual behavior. Physiol Behav. 2004, 83:291–307.PubMedGoogle Scholar
  20. 20.
    Shores M, Pascualy M, Lewis N, Flatness D, Veith R: Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects. Psychoneuroendocrino. 2001, 26:433–439.CrossRefGoogle Scholar
  21. 21.
    Barton D, Dawood T, Lambert E, et al.: Sympathetic activity in major depressive disorder: Identifying those at increased cardiac risk? J Hypertens. 2007, 25:2117–2124.PubMedCrossRefGoogle Scholar
  22. 22.
    Licht C, Penninx B, de Geus E: Response to depression and blood pressure control: All antidepressants are not the same. Hypertension. 2009, 54:e2.CrossRefGoogle Scholar
  23. 23.
    Bradford A, Meston C: Autonomic nervous system influences: The role of the sympathetic nervous system in female sexual arousal. The Psychophysiology of Sex. Bloomington, Indiana: Indiana University Press, 2007, 66-82.Google Scholar
  24. 24.
    Lorenz TK, Harte CB, Hamilton LD, Meston CM: Evidence for a curvilinear relationship between SNS activation and women’s sexual arousal. Psychophysiology. in press.Google Scholar
  25. 25.
    Meston CM: A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction. J Sex Marital Ther. 2004, 30:57–68.PubMedCrossRefGoogle Scholar
  26. 26.
    Ahrold T, Meston C: Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI. J Sex Marital Ther. 2009, 35:311–319.PubMedCrossRefGoogle Scholar
  27. 27.
    Bymaster FP, Zhang W, Carter PA, et al.: Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl). 2002, 160:353–361.CrossRefGoogle Scholar
  28. 28.
    Perry K, Fuller R: Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO 4 and microdialysis in conscious rats. J Neural Transm. 1997, 104:953–966.PubMedCrossRefGoogle Scholar
  29. 29.
    Sanchez C, Hyttel J: Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol. 1999, 19:467–489.PubMedCrossRefGoogle Scholar
  30. 30.
    Meston CM, Gorzalka BB: The effects of immediate, delayed, and residual sympathetic activation on sexual arousal in women. Behav Res Ther. 1996, 34:143–148.PubMedCrossRefGoogle Scholar
  31. 31.
    Meston CM, Gorzalka BB: Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol. 1996, 105:582–591.PubMedCrossRefGoogle Scholar
  32. 32.
    Hoffman B, Babyak M, Sherwood A, et al.: Effects of aerobic exercise on sexual functioning in depressed adults. Mental Health and Physical Activity. 2009, 2:23–28.CrossRefGoogle Scholar
  33. 33.
    Chivers ML, Seto MC, Lalumière ML, Laan E, Grimbos T: Agreement of sef-reported and genital measures of sexual arousal in men and women: A meta-analysis. Arch Sex Behav. 2010, 39:5–56.PubMedCrossRefGoogle Scholar
  34. 34.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (Revised 4th Ed.). Washington, DC: Author, 2000.Google Scholar
  35. 35.
    Pischon T, Boeing H, Hoffmann K, et al.: General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008, 359:2105–2120.PubMedCrossRefGoogle Scholar
  36. 36.
    Gellish RL, Goslin BR, Olson RE, et al.: Longitudinal modeling of the relationship between age and maximal heart rate. Med Sci Sports Exerc. 2007, 39:822–829.PubMedGoogle Scholar
  37. 37.
    Hamilton LD, Fogle EA, Meston CM: The roles of testosterone and alpha-amylase in exercise-induced sexual arousal in women. Journal of Sexual Medicine. 2008, 5:845–853.PubMedCrossRefGoogle Scholar
  38. 38.
    Laan E, Everaerd W, van Bellen G, Hanewald G: Women’s sexual and emotional responses to male- and female-produced erotica. Arch Sex Behav. 1994, 23:153–169.PubMedCrossRefGoogle Scholar
  39. 39.
    Laan E, Everaerd W, Evers A: Assessment of female sexual arousal: Response specificity and construct validity. Psychophysiology. 1995, 32:476–485.PubMedCrossRefGoogle Scholar
  40. 40.
    Laan E, van Driel E, van Lunsen R: Genital responsiveness in healthy women with and without sexual arousal disorder. Journal of Sexual Medicine. 2008, 5:1424–1435.PubMedCrossRefGoogle Scholar
  41. 41.
    Harte C, Meston C: Gender comparisons in the concordance between physiological and subjective sexual arousal. International Society for the Study of Women’s Sexual Health. Orlando, FL, 2007.Google Scholar
  42. 42.
    Harte C, Meston C: The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: Results from a randomized, double blind, placebo controlled, cross over trial. Journal of Sexual Medicine. 2008, 5:1184–1197.PubMedCrossRefGoogle Scholar
  43. 43.
    Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation. 1996, 93:1043–1065.CrossRefGoogle Scholar
  44. 44.
    Heiman J, Rowland D: Affective and physiological sexual response patterns: The effects of instructions on sexually functional and dysfunctional men. J Psychosom Res. 1983, 27:105–116.PubMedCrossRefGoogle Scholar
  45. 45.
    Brotto L: The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Arch Sex Behav. 2010, 39:221–239.PubMedCrossRefGoogle Scholar
  46. 46.
    Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC: Hypoactive sexual desire disorder in postmenopausal women: US results from the Women’s International Study of Health and Sexuality (WISHeS). Menopause. 2006, 13:46–56.PubMedCrossRefGoogle Scholar
  47. 47.
    Rosen RC, Brown C, Heiman JR, et al.: The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000, 26:191–208.PubMedCrossRefGoogle Scholar
  48. 48.
    Ottesen B, Pedersen B, Nielsen J, et al.: Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides. 1987, 8:797–800.PubMedCrossRefGoogle Scholar
  49. 49.
    Wiegel M, Meston CM, Rosen R: The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005, 31:1–20.PubMedCrossRefGoogle Scholar
  50. 50.
    Thomas MSC, Annaz D, Ansari D, et al.: Using developmental trajectories to understand developmental disorders. J Speech Lang Hear Res. 2009, 52:336–358.PubMedCrossRefGoogle Scholar
  51. 51.
    Carmeliet P, Tessier-Lavigne M: Common mechanisms of nerve and blood vessel wiring. Nature. 2005, 436:193–200.PubMedCrossRefGoogle Scholar
  52. 52.
    von Heyden B, Riemer R, Nunes L, et al.: Response of guinea pig smooth and striated urethral sphincter to cromakalim, prazosin, nifedipine, nitroprusside, and electrical stimulation. Neurourol Urodyn. 1995, 14:153–168.CrossRefGoogle Scholar
  53. 53.
    Davison T, McCabe M: Relationships between men’s and women’s body image and their psychological, social, and sexual functioning. Sex Roles. 2005, 52:463–475.CrossRefGoogle Scholar
  54. 54.
    Lawlor D, Hopker S: The effectiveness of exercise as an intervention in the management of depression: Systematic review and meta-regression analysis of randomised controlled trials. Br Med J. 2001, 322:1–8.CrossRefGoogle Scholar
  55. 55.
    Dove NL, Wiederman MW: Cognitive distraction and women’s sexual functioning. J Sex Marital Ther. 2000, 26:67–78.PubMedCrossRefGoogle Scholar
  56. 56.
    Masters W, Johnson V: Human Sexual Inadequacy. Boston: Little Brown, 1970.Google Scholar
  57. 57.
    Brotto L, Gorzalka B: Genital and subjective sexual arousal in postmenopausal women: Influence of laboratory-induced hyperventilation. J Sex Marital Ther. 2002, 28:39–53.PubMedGoogle Scholar
  58. 58.
    Schueller PO, Feuring M, Sharkova Y, Grimm W, Christ M: Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive age. Int J Cardiol. 2006, 111:42–48.PubMedCrossRefGoogle Scholar
  59. 59.
    Sanders SA, Graham CA, Bass JL, Bancroft J: A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001, 64:51–58.PubMedCrossRefGoogle Scholar
  60. 60.
    Blumenthal J, Babyak M, Moore K, et al.: Effects of exercise training on older patients with major depression. Arch Intern Med. 1999, 159:2349–2356.PubMedCrossRefGoogle Scholar
  61. 61.
    Tschakovsky M, Joyner M: Nitric oxide and muscle blood flow in exercise. Appl Physiol Nutr Me. 2008, 33:151–154.CrossRefGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2012

Authors and Affiliations

  1. 1.Department of PsychologyUniversity of Texas at AustinAustinUSA

Personalised recommendations